36 Participants Needed

Controlled Breathing for COPD

(REST Trial)

KK
KK
Overseen ByKristina Kashyap
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: University of Texas at Austin
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

Trial Summary

Do I have to stop taking my current medications for the trial?

The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.

What data supports the effectiveness of the treatment REST, Controlled Breathing Intervention, REST Program for COPD?

Research shows that controlled breathing can help people with COPD by reducing breathlessness, improving breathing muscle strength, and enhancing quality of life. Techniques like pursed-lips breathing and group breathing exercises have shown benefits in improving symptoms and overall well-being in COPD patients.12345

Is controlled breathing safe for humans?

Research on tele-pulmonary rehabilitation, which includes controlled breathing techniques, shows it is safe for people with COPD, as no major adverse events were reported in a study involving 177 participants.678910

How is the REST treatment different from other treatments for COPD?

The REST treatment, which involves controlled breathing exercises, is unique because it focuses on improving breathing patterns and reducing breathlessness by strengthening respiratory muscles and optimizing breathing techniques. Unlike standard drug treatments, it is a non-drug approach that can be delivered in group settings, potentially enhancing its benefits for patients with COPD.1341011

What is the purpose of this trial?

This is a parallel design, randomized, controlled pilot trial comparing a controlled breath intervention (REST) to usual care for reducing stress in individuals with COPD.

Eligibility Criteria

This trial is for people over 40 with confirmed COPD, who experience significant stress and shortness of breath. Participants must have a certain score on the COPD Assessment Test, be able to attend training sessions in person, and communicate in English.

Inclusion Criteria

I can attend 2 in-person sessions.
I can read, write, and speak English.
My COPD symptoms are moderate to severe.
See 3 more

Timeline

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Intervention

Participants receive the REST (controlled breath) intervention and COPD education

6 months
2 in-person sessions (1 training, 1 trial)

Follow-up

Participants are monitored for acceptability, feasibility, and stress measures

6 months

Treatment Details

Interventions

  • REST
Trial Overview The REST trial compares a controlled breathing technique designed to reduce stress against usual care practices for individuals with COPD. It's a pilot study where participants are randomly assigned to one of the two groups.
Participant Groups
2Treatment groups
Experimental Treatment
Active Control
Group I: Behavioral Intervention (REST)Experimental Treatment1 Intervention
Participants randomized to this group will receive COPD education, research staff support, and the REST (controlled breath) intervention.
Group II: ControlActive Control1 Intervention
Participants randomized to this group will receive COPD education and research staff support.

Find a Clinic Near You

Who Is Running the Clinical Trial?

University of Texas at Austin

Lead Sponsor

Trials
387
Recruited
86,100+

Findings from Research

Controlled breathing techniques, such as pursed-lips breathing and inspiratory muscle training, have been shown to effectively relieve dyspnea in patients with chronic obstructive pulmonary disease (COPD) by improving gas exchange and respiratory muscle strength.
Despite the benefits of controlled breathing, further research is needed to determine how well these techniques can be applied during daily activities and their overall impact on functional adaptations in COPD patients.
Controlled breathing and dyspnea in patients with chronic obstructive pulmonary disease (COPD).Gosselink, R.[2022]
Oxygen supplementation and slow breathing techniques have strong and moderate evidence, respectively, for significantly improving baroreceptor sensitivity (BRS) in patients with chronic obstructive pulmonary disease (COPD), based on a systematic review of 18 studies.
Despite the positive effects on BRS, the long-term therapeutic benefits of these interventions on overall autonomic function in COPD patients remain unclear.
Effect of respiratory rehabilitation techniques on the autonomic function in patients with chronic obstructive pulmonary disease: A systematic review.Mohammed, J., Da Silva, H., Van Oosterwijck, J., et al.[2018]
Capnography-assisted respiratory therapy (CART) is a new mind-body approach that effectively integrates real-time CO2 biofeedback with traditional pulmonary rehabilitation (PR) to address dysfunctional breathing behaviors in COPD patients, showing high feasibility with 74% session completion.
Participants in the CART+PR group experienced significant improvements in dyspnea, respiratory rate, and physical function, indicating that this therapy may enhance exercise tolerance and adherence to rehabilitation programs in COPD patients.
Mind-Body Intervention for Dysfunctional Breathing in Chronic Obstructive Pulmonary Disease: Feasibility Study and Lessons Learned.Norweg, AM., Wu, Y., Troxel, A., et al.[2023]

References

Controlled breathing and dyspnea in patients with chronic obstructive pulmonary disease (COPD). [2022]
Effect of respiratory rehabilitation techniques on the autonomic function in patients with chronic obstructive pulmonary disease: A systematic review. [2018]
Mind-Body Intervention for Dysfunctional Breathing in Chronic Obstructive Pulmonary Disease: Feasibility Study and Lessons Learned. [2023]
Breathing Control Exercises Delivered in a Group Setting for Patients with Chronic Obstructive Pulmonary Disease: A Randomized Controlled Trial. [2023]
The effects of controlled breathing during pulmonary rehabilitation in patients with COPD. [2012]
The Accessibility, Feasibility, and Safety of a Standardized Community-based Tele-Pulmonary Rehab Program for Chronic Obstructive Pulmonary Disease: A 3-Year Real-World Prospective Study. [2022]
A randomised crossover trial comparing volume assured and pressure preset noninvasive ventilation in stable hypercapnic COPD. [2010]
Effects of an animated diagram and video-based online breathing program for dyspnea in patients with stable COPD. [2021]
[Easy come, easy go? Current strategies for maintaining the effects of pulmonary rehabilitation in COPD patients]. [2020]
Home Based Pulmonary Rehabilitation on Oxygenation Status, Dyspnea and Fatigue in Stable Patients with COPD. [2020]
11.United Statespubmed.ncbi.nlm.nih.gov
Pranayam for Treatment of Chronic Obstructive Pulmonary Disease: Results From a Randomized, Controlled Trial. [2022]
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Terms of Service·Privacy Policy·Cookies·Security